Vertex Pharmaceuticals
All companiesCompany report · generated from Vertex Pharmaceuticals's indicators
Vertex Pharmaceuticals — full AI read
Vertex Pharmaceuticals (Biotechnology, United States) — $121bn market cap. AI Influence (AII) –, Corporate Power 50.7.
Sector
Biotechnology
HQ
Boston, United States
Ownership
Public
Revenue
$11bn
Market cap / valuation
$121bn
Employees
6k
AI Influence (AII)
—
Corporate Power (CPX)
50.7
Dimension read
| Dimension | Value | Standing | What a high vs low value means — and where Vertex Pharmaceuticals sits |
|---|---|---|---|
| AII AI Influence (AII) | – | Lagging · #None/208 | Low here — limited influence over AI's direction. ▲ high: a company that powerfully shapes the AI world · ▼ low: limited influence over AI's direction |
| CPX Corporate Power (CPX) | 50.7 | Moderate · #207/348 | Mid-pack. High would mean a civilization-shaping heavyweight — vast market cap, reach and strategic leverage; low would mean limited absolute power to shape global affairs. ▲ high: a civilization-shaping heavyweight — vast market cap, reach and strategic leverage · ▼ low: limited absolute power to shape global affairs |
| Frontier capability Frontier capability | 14.0 | Developing · #237/348 | Low here — far from the AI frontier. ▲ high: at or defining the AI frontier (model quality & research) · ▼ low: far from the AI frontier |
| AI criticality AI criticality | 18.0 | Developing · #233/348 | Low here — not critical to the AI ecosystem. ▲ high: a foundational chokepoint the AI ecosystem is built on · ▼ low: not critical to the AI ecosystem |
| Leadership influence Leadership influence | 50.0 | Moderate · #203/348 | Mid-pack. High would mean led by a major AI/world power-broker; low would mean leadership with limited outside influence. ▲ high: led by a major AI/world power-broker · ▼ low: leadership with limited outside influence |
| AI momentum AI momentum | 44.0 | Developing · #233/348 | Low here — flat or fading AI momentum. ▲ high: surging adoption and mindshare · ▼ low: flat or fading AI momentum |
| CAI Corporate AI (CAI) | 39.9 | Developing · #254/348 | Low here — an AI laggard relative to peers. ▲ high: an AI leader — deep adoption, talent and AI-centric products · ▼ low: an AI laggard relative to peers |
| AI-stack independence AI-stack independence | 22.0 | Moderate · #220/348 | Mid-pack. High would mean owns its own models, AI silicon and cloud — vertically independent; low would mean depends on others' models, chips or cloud. ▲ high: owns its own models, AI silicon and cloud — vertically independent · ▼ low: depends on others' models, chips or cloud |
| Strategic leverage Strategic leverage | 58.0 | Moderate · #193/348 | Mid-pack. High would mean outsized sway over policy, markets and standards; low would mean limited leverage beyond its size. ▲ high: outsized sway over policy, markets and standards · ▼ low: limited leverage beyond its size |
Strengths
- No standout dimension.
Risk factors
- Immature AI governance (48): responsible-AI controls trail capability — a reputational/regulatory exposure.
- Relative weakness — AI Influence (AII) (–, Lagging): limited influence over AI's direction.
▲
These are model outputs and scenarios, not forecasts of actual outcomes. This platform measures access to, utilization of, and leverage from cognitive infrastructure — not intelligence. No causality or certainty is claimed.